Style | Citing Format |
---|---|
MLA | Rizi ZS, et al.. "Drug Response of Iranian Alzheimer’S Patients to Rivastigmine Concerning Their Genotype for Vdr Rs11568820 and Mthfr C677t Variants: A Pharmacogenetic and Association Study." Journal of Molecular Neuroscience, vol. 74, no. 3, 2024, pp. -. |
APA | Rizi ZS, Shams L, Rad FR, Zamani M (2024). Drug Response of Iranian Alzheimer’S Patients to Rivastigmine Concerning Their Genotype for Vdr Rs11568820 and Mthfr C677t Variants: A Pharmacogenetic and Association Study. Journal of Molecular Neuroscience, 74(3), -. |
Chicago | Rizi ZS, Shams L, Rad FR, Zamani M. "Drug Response of Iranian Alzheimer’S Patients to Rivastigmine Concerning Their Genotype for Vdr Rs11568820 and Mthfr C677t Variants: A Pharmacogenetic and Association Study." Journal of Molecular Neuroscience 74, no. 3 (2024): -. |
Harvard | Rizi ZS et al. (2024) 'Drug Response of Iranian Alzheimer’S Patients to Rivastigmine Concerning Their Genotype for Vdr Rs11568820 and Mthfr C677t Variants: A Pharmacogenetic and Association Study', Journal of Molecular Neuroscience, 74(3), pp. -. |
Vancouver | Rizi ZS, Shams L, Rad FR, Zamani M. Drug Response of Iranian Alzheimer’S Patients to Rivastigmine Concerning Their Genotype for Vdr Rs11568820 and Mthfr C677t Variants: A Pharmacogenetic and Association Study. Journal of Molecular Neuroscience. 2024;74(3):-. |
BibTex | @article{ author = {Rizi ZS and Shams L and Rad FR and Zamani M}, title = {Drug Response of Iranian Alzheimer’S Patients to Rivastigmine Concerning Their Genotype for Vdr Rs11568820 and Mthfr C677t Variants: A Pharmacogenetic and Association Study}, journal = {Journal of Molecular Neuroscience}, volume = {74}, number = {3}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Rizi ZS AU - Shams L AU - Rad FR AU - Zamani M TI - Drug Response of Iranian Alzheimer’S Patients to Rivastigmine Concerning Their Genotype for Vdr Rs11568820 and Mthfr C677t Variants: A Pharmacogenetic and Association Study JO - Journal of Molecular Neuroscience VL - 74 IS - 3 SP - EP - PY - 2024 ER - |